On the one hand, VCAM-1, MCP-1 and ADMA levels were increased in patients with RA-ILD+ in relation to RA-ILD- patients (p < 0.01 in all cases, Figures 1A,C,E, Supplementary Table S1). This evidence concerns the gene CCL2 and rheumatoid arthritis.